Published in EMBO J on February 15, 1995
N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev (2000) 3.62
ABI2-deficient mice exhibit defective cell migration, aberrant dendritic spine morphogenesis, and deficits in learning and memory. Mol Cell Biol (2004) 1.70
alpha4beta1 integrin regulates lamellipodia protrusion via a focal complex/focal adhesion-independent mechanism. Mol Biol Cell (2002) 1.45
Expression and activity of L-Myc in normal mouse development. Mol Cell Biol (1996) 1.36
Early fetal hypoxia leads to growth restriction and myocardial thinning. Am J Physiol Regul Integr Comp Physiol (2008) 1.19
Dystrophic muscle in mice chimeric for expression of alpha5 integrin. J Cell Biol (1998) 1.18
Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomas. Am J Pathol (2003) 0.90
Disruption of retinoblastoma protein family function by human papillomavirus type 16 E7 oncoprotein inhibits lens development in part through E2F-1. Mol Cell Biol (1999) 0.87
Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo. Mol Cell Biol (1999) 0.87
Lens complementation system for the genetic analysis of growth, differentiation, and apoptosis in vivo. Proc Natl Acad Sci U S A (1996) 0.83
c-Myc regulates cell proliferation during lens development. PLoS One (2014) 0.82
Identification and characterization of FGF2-dependent mRNA: microRNA networks during lens fiber cell differentiation. G3 (Bethesda) (2013) 0.82
Elevated proto-oncogene and collagen mRNA expression in PVR retinas. Graefes Arch Clin Exp Ophthalmol (2003) 0.75
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol (1992) 34.17
Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem (1980) 26.55
Induction of apoptosis in fibroblasts by c-myc protein. Cell (1992) 16.95
Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science (1991) 12.00
Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A (1982) 11.15
Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science (1982) 10.61
Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci U S A (1982) 10.50
Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature (1983) 8.18
Sequence-specific DNA binding by the c-Myc protein. Science (1990) 7.75
Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell (1993) 6.40
Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas. Nature (1983) 5.97
Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell (1991) 5.76
Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell (1993) 5.28
L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature (1985) 4.66
p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature (1994) 4.52
Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science (1991) 4.45
An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol Cell Biol (1990) 4.24
Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell (1983) 4.13
Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment. Nature (1986) 3.86
Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell (1986) 3.70
Lens differentiation in vertebrates. A review of cellular and molecular features. Differentiation (1981) 3.65
A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev (1993) 3.60
Differential expression of myc family genes during murine development. Nature (1986) 3.57
Oncogenesis of the lens in transgenic mice. Science (1987) 3.40
Regressive events in neurogenesis. Science (1984) 3.24
Myc and Max associate in vivo. Genes Dev (1992) 3.16
Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line. Nature (1982) 3.05
Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development (1992) 3.04
Two human c-onc genes are located on the long arm of chromosome 8. Proc Natl Acad Sci U S A (1982) 3.02
Max: functional domains and interaction with c-Myc. Genes Dev (1992) 2.88
Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature (1991) 2.78
Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev (1992) 2.72
A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev (1993) 2.65
Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line. Nature (1986) 2.57
Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation. Nature (1986) 2.54
Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev (1992) 2.54
Mouse c-myc oncogene is located on chromosome 15 and translocated to chromosome 12 in plasmacytomas. Science (1982) 2.40
Structure and expression of the murine N-myc gene. Proc Natl Acad Sci U S A (1986) 2.36
The human myc gene family: structure and activity of L-myc and an L-myc pseudogene. Genes Dev (1987) 2.33
Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev (1992) 2.33
The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology (1991) 2.32
Cell death during differentiation of the retina in the mouse. J Comp Neurol (1984) 2.29
Lens-specific expression and developmental regulation of the bacterial chloramphenicol acetyltransferase gene driven by the murine alpha A-crystallin promoter in transgenic mice. Proc Natl Acad Sci U S A (1985) 2.22
Oncogene-induced liver neoplasia in transgenic mice. Oncogene (1989) 2.20
Determination of the c-MYC DNA-binding site. Proc Natl Acad Sci U S A (1991) 2.19
The role of c-myc in cell growth. Curr Opin Genet Dev (1993) 2.17
myc family oncogenes in the development of normal and neoplastic cells. Adv Cancer Res (1991) 2.08
TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein. Proc Natl Acad Sci U S A (1993) 2.00
Use of bromodeoxyuridine-immunohistochemistry to examine the proliferation, migration and time of origin of cells in the central nervous system. Brain Res (1988) 1.99
Binding and suppression of the Myc transcriptional activation domain by p107. Science (1994) 1.84
Differentiation and oncogenesis: phenotypically distinct lens tumors in transgenic mice. New Biol (1989) 1.82
Structure and expression of the human L-myc gene reveal a complex pattern of alternative mRNA processing. Mol Cell Biol (1988) 1.78
The c-myc proto-oncogene regulates cardiac development in transgenic mice. Mol Cell Biol (1990) 1.76
Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo. Genes Dev (1989) 1.74
Expression of N-myc in teratocarcinoma stem cells and mouse embryos. Nature (1985) 1.72
Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants. Genes Dev (1992) 1.68
Enhanced expression of the N-myc gene in Wilms' tumors. Cancer Res (1986) 1.67
Lens-specific expression of the chloramphenicol acetyltransferase gene promoted by 5' flanking sequences of the murine alpha A-crystallin gene in explanted chicken lens epithelia. Proc Natl Acad Sci U S A (1985) 1.65
Cascade induction of c-fos, c-myc, and heat shock 70K transcripts during regression of the rat ventral prostate gland. Mol Endocrinol (1988) 1.65
Structure and expression of the murine L-myc gene. EMBO J (1987) 1.64
Immunocytochemical localization of the lens main intrinsic polypeptide (MIP26) in communicating junctions. J Cell Biol (1982) 1.64
C-myc as an inducer of polycystic kidney disease in transgenic mice. Kidney Int (1991) 1.63
Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1. Proc Natl Acad Sci U S A (1994) 1.56
Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. Development (1993) 1.55
Sequence-specific DNA binding by Myc proteins. Proc Natl Acad Sci U S A (1991) 1.55
Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation. J Virol (1993) 1.54
The N-Myc oncoprotein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells. EMBO J (1991) 1.52
N-myc proto-oncogene expression during organogenesis in the developing mouse as revealed by in situ hybridization. J Cell Biol (1988) 1.47
L-myc cooperates with ras to transform primary rat embryo fibroblasts. Mol Cell Biol (1988) 1.43
Targeted c-myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcription. EMBO J (1988) 1.41
Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells. Mol Cell Biol (1992) 1.39
Dynamic expression pattern of the myc protooncogene in midgestation mouse embryos. Science (1989) 1.24
Control of lens epithelial cell survival. J Cell Biol (1993) 1.24
Contrasting expression patterns of three members of the myc family of protooncogenes in the developing and adult mouse kidney. J Cell Biol (1991) 1.23
Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer. Semin Cancer Biol (1994) 1.23
Heat induced aggregation of the sodium dodecyl sulfate-solubilized main intrinsic polypeptide isolated from bovine lens plasma membrane. Biochem Biophys Res Commun (1978) 1.18
The human L-myc gene encodes multiple nuclear phosphoproteins from alternatively processed mRNAs. Mol Cell Biol (1988) 1.18
Lens membranes II. Isolation and characterization of the main intrinsic polypeptide (MIP) of bovine lens fiber membranes. Exp Eye Res (1976) 1.15
Complex lymphoid and epithelial thymic tumours in Thy1-myc transgenic mice. Nature (1989) 1.13
Induction of the eye lens. Differentiation (1980) 1.12
Determination of the DNA sequence recognized by the bHLH-zip domain of the N-Myc protein. Nucleic Acids Res (1992) 1.11
DNA binding by N- and L-Myc proteins. Oncogene (1993) 1.11
A comparative analysis of N-myc and c-myc expression and cellular proliferation in mouse organogenesis. Mech Dev (1991) 1.08
Zebra fish myc family and max genes: differential expression and oncogenic activity throughout vertebrate evolution. Mol Cell Biol (1993) 1.07
Structural organization of the murine c-kit proto-oncogene. Oncogene (1992) 1.04
The role of cell death during morphogenesis of the mammalian eye. J Morphol (1973) 1.04
IgH enhancer deregulated expression of L-myc: abnormal T lymphocyte development and T cell lymphomagenesis. EMBO J (1990) 1.00
Expression of N-myc and c-src during the development of fetal human brain. Cancer Res (1987) 0.99
Effects of fixation time and enzymatic digestion on immunohistochemical demonstration of bromodeoxyuridine in formalin-fixed, paraffin-embedded tissue. J Histochem Cytochem (1988) 0.98
Functional analysis at the Cys706 residue of the retinoblastoma protein. J Biol Chem (1992) 0.98
Nuclear events after activation of CD4+8+ thymocytes. J Immunol (1990) 0.96
Mechanism of endogenous myc gene down-regulation in E mu-N-myc tumors. Mol Cell Biol (1991) 0.95
Chromosomal location of N-myc and L-myc genes in the mouse. Oncogene Res (1989) 0.93
Perturbed development of the mouse lens by polyomavirus large T antigen does not lead to tumor formation. Genes Dev (1989) 0.92
Changes in membrane protein pattern in relation to lens cell differentiation. FEBS Lett (1977) 0.90
Complex transcriptional regulation of myc family gene expression in the developing mouse brain and liver. Mol Cell Biol (1991) 0.87
c-myc mRNA is elevated as differentiating lens cells withdraw from the cell cycle. Exp Cell Res (1987) 0.84
Changes in the major intrinsic polypeptide (MIP26K) during opacification of the Emory mouse lens. Exp Eye Res (1988) 0.81
A transfected L-myc gene can substitute for c-myc in blocking murine erythroleukemia differentiation. Mol Cell Biol (1989) 0.78
Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell (1997) 13.34
The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature (1999) 12.60
Role of the INK4a locus in tumor suppression and cell mortality. Cell (1996) 11.41
ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell (1991) 9.54
The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell (1998) 8.33
Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature (1997) 7.66
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature (2000) 7.28
Essential role of mouse telomerase in highly proliferative organs. Nature (1998) 7.23
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature (2001) 7.06
Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell (1999) 6.98
Malignant glioma: genetics and biology of a grave matter. Genes Dev (2001) 6.78
Essential role for oncogenic Ras in tumour maintenance. Nature (1999) 6.51
p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell (1999) 5.93
Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J Clin Invest (1997) 5.19
Cellular senescence: mitotic clock or culture shock? Cell (2000) 5.17
A functional T3 molecule associated with a novel heterodimer on the surface of immature human thymocytes. Nature (1986) 4.95
Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature (1997) 4.82
Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature (2000) 4.75
p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature (1994) 4.52
Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity (2001) 4.09
Transcripts from both strands of a satellite DNA occur on lampbrush chromosome loops of the newt Notophthalmus. Cell (1981) 3.92
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86
DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol Cell (2000) 3.82
An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell (1995) 3.68
A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev (1998) 3.68
Regulation of genome rearrangement events during lymphocyte differentiation. Immunol Rev (1986) 3.65
N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev (2000) 3.62
The INK4A/ARF locus and its two gene products. Curr Opin Genet Dev (1999) 3.50
Oncogenesis of the lens in transgenic mice. Science (1987) 3.40
Human N-myc is closely related in organization and nucleotide sequence to c-myc. Nature (1986) 3.40
The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc Natl Acad Sci U S A (2000) 3.21
The Rx homeobox gene is essential for vertebrate eye development. Nature (1997) 3.08
Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet (2001) 2.92
Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science (2000) 2.67
Laparoscopic cholecystectomy, bile duct injury and the British and Irish surgeon. Ann R Coll Surg Engl (1998) 2.66
Value of graduated compression stockings in deep venous insufficiency. Br Med J (1980) 2.65
Secondary genomic rearrangement events in pre-B cells: VHDJH replacement by a LINE-1 sequence and directed class switching. EMBO J (1986) 2.62
Reversal of left-right asymmetry: a situs inversus mutation. Science (1993) 2.56
Involvement of a novel Tnf receptor homologue in hair follicle induction. Nat Genet (1999) 2.54
Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene (1998) 2.49
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev (1997) 2.47
Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell (1999) 2.46
Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science (1995) 2.42
Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development. Genes Dev (1998) 2.39
Structure and expression of the murine N-myc gene. Proc Natl Acad Sci U S A (1986) 2.36
Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat Genet (2000) 2.34
Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene (1999) 2.34
TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat Med (2000) 2.29
Mutations in the human homologue of mouse dl cause autosomal recessive and dominant hypohidrotic ectodermal dysplasia. Nat Genet (1999) 2.29
Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene (1998) 2.27
Lens-specific expression and developmental regulation of the bacterial chloramphenicol acetyltransferase gene driven by the murine alpha A-crystallin promoter in transgenic mice. Proc Natl Acad Sci U S A (1985) 2.22
Gene-target recognition among members of the myc superfamily and implications for oncogenesis. Nat Genet (2000) 2.19
Specification of pituitary cell lineages by the LIM homeobox gene Lhx3. Science (1996) 2.18
Conserved cysteine to serine mutation in tyrosinase is responsible for the classical albino mutation in laboratory mice. Nucleic Acids Res (1990) 2.13
Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J Biol Chem (1998) 2.10
DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation. Nat Cell Biol (2001) 2.09
myc family oncogenes in the development of normal and neoplastic cells. Adv Cancer Res (1991) 2.08
Placental failure in mice lacking the homeobox gene Dlx3. Proc Natl Acad Sci U S A (1999) 1.96
A transgenic insertion upstream of sox9 is associated with dominant XX sex reversal in the mouse. Nat Genet (2000) 1.95
Gene defect in ectodermal dysplasia implicates a death domain adapter in development. Nature (2002) 1.95
Cloning of inv, a gene that controls left/right asymmetry and kidney development. Nature (1998) 1.90
A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr Opin Genet Dev (2000) 1.88
Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression. Genes Dev (2000) 1.87
Telomere dysfunction triggers developmentally regulated germ cell apoptosis. Mol Biol Cell (2001) 1.85
Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc Natl Acad Sci U S A (2001) 1.83
Differentiation and oncogenesis: phenotypically distinct lens tumors in transgenic mice. New Biol (1989) 1.82
Multistep control of pituitary organogenesis. Science (1997) 1.82
Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature (1998) 1.82
Regulation of mouse lens fiber cell development and differentiation by the Maf gene. Development (2000) 1.75
p19ARF targets certain E2F species for degradation. Proc Natl Acad Sci U S A (2001) 1.75
Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection. Proc Natl Acad Sci U S A (1997) 1.74
p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation. Proc Natl Acad Sci U S A (1998) 1.73
Dual inactivation of RB and p53 pathways in RAS-induced melanomas. Mol Cell Biol (2001) 1.73
Calmodulin-induced early-onset diabetes in transgenic mice. Cell (1989) 1.71
Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphotoreceptor retinoid-binding protein promoter. J Cell Biol (1992) 1.70
Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants. Genes Dev (1992) 1.68
Formation of Rathke's pouch requires dual induction from the diencephalon. Development (1998) 1.68
Impaired nonhomologous end-joining provokes soft tissue sarcomas harboring chromosomal translocations, amplifications, and deletions. Mol Cell (2001) 1.68
Malignant melanoma: modern black plague and genetic black box. Genes Dev (1998) 1.67
Tissue-specific expression in transgenic mice of a fused gene containing RSV terminal sequences. Science (1986) 1.64
The INK4a/ARF tumor suppressor: one gene--two products--two pathways. Trends Biochem Sci (1998) 1.59
Differential and overlapping expression domains of Dlx-2 and Dlx-3 suggest distinct roles for Distal-less homeobox genes in craniofacial development. Mech Dev (1994) 1.57
FGF10 is an inducer and Pax6 a competence factor for lacrimal gland development. Development (2000) 1.57
Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1. Proc Natl Acad Sci U S A (1994) 1.56
Extracellular FGF-1 acts as a lens differentiation factor in transgenic mice. Development (1995) 1.53
Significance of popliteal reflux in relation to ambulatory venous pressure and ulceration. Arch Surg (1979) 1.50
Essential role for Max in early embryonic growth and development. Genes Dev (2000) 1.46
Repression by the Mad(Mxi1)-Sin3 complex. Bioessays (1998) 1.45
Photoreceptor degeneration induced by the expression of simian virus 40 large tumor antigen in the retina of transgenic mice. Proc Natl Acad Sci U S A (1992) 1.44
Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. Proc Natl Acad Sci U S A (1998) 1.41
Hypogonadism and obesity in mice with a targeted deletion of the Nhlh2 gene. Nat Genet (1997) 1.41